Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial
Nuntakorn Thongtang, Jirasak Piyapromdee, Natthakan Tangkittikasem, Kittichai Samaithongcharoen, Nithiwat Srikanchanawat, Sutin Sriussadaporn Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandCorrespondence: N...
Saved in:
Main Authors: | Thongtang N, Piyapromdee J, Tangkittikasem N, Samaithongcharoen K, Srikanchanawat N, Sriussadaporn S |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/39eb2b7810c149ce9955e1487e169e7f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association of Contemporary Statin Pretreatment Intensity and LDL-C Levels on the Incidence of STEMI Presentation
by: Ziv Dadon, et al.
Published: (2021) -
Statin Use and Adverse Effects Among Adults >75 Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry
by: Michael G. Nanna, et al.
Published: (2018) -
Determinants of Statin Initiation Among Adult Diabetic Patients in Bonga, Ethiopia
by: Kebede zelalem B, et al.
Published: (2020) -
Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly
by: Sydney B Long, et al.
Published: (2010) -
Statins in the primary prevention of cardiovascular disease. Rosuvastatin capabilities
by: Marina G. Bubnova, et al.
Published: (2021)